Skip to main content

Healthcare & PharmaceuticalsEuropean Medicines Agency: More than 300 cases of rare blood clot events worldwide

Reuters
1 minute read

The exterior of the European Medicines Agency is seen in Amsterdam, Netherlands, December 18, 2020. REUTERS/Piroschka van de Wouw

The European Union’s drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.

There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson’s shot, 25 for Pfizer and five for Moderna, said Peter Arlett, Head of Data Analytics at the European Medicines Agency (EMA).

Our Standards: The Thomson Reuters Trust Principles.

Healthcare & Pharmaceuticals

Healthcare & Pharmaceuticals · May 12, 2021 · 8:48 PM UTCGlobal concern grows as COVID-19 variant ravages rural India

India's coronavirus death toll crossed 250,000 on Wednesday in the deadliest 24 hours since the pandemic began, as the disease rampaged through the countryside, leaving families to weep over the dead in rural hospitals or camp in wards to tend the sick.

Healthcare & PharmaceuticalsHow can we stop the next pandemic? Here's what WHO panel recommends
Healthcare & PharmaceuticalsDelaying second COVID-19 vaccine doses can help reduce deaths - study
Healthcare & PharmaceuticalsmRNA vaccines appear effective vs India variant; people with HIV at higher risk for severe COVID-19

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Healthcare & PharmaceuticalsExplainer: Should my teen get the COVID-19 vaccine?